Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Apr 6, 2022; 10(10): 3206-3212
Published online Apr 6, 2022. doi: 10.12998/wjcc.v10.i10.3206
Myomatous erythrocytosis syndrome: A case report
Xin-Yu Shu, Na Chen, Bi-Yun Chen, Hui-Xia Yang, Hui Bi
Xin-Yu Shu, Bi-Yun Chen, Hui-Xia Yang, Hui Bi, Department of Obstetrics and Gynaecology, Peking University First Hospital, Beijing 100034, China
Na Chen, Department of Obstetrics and Gynaecology, The Hospital of Cang Town, Cangzhou 223900, Hebei Province, China
Author contributions: Shu XY wrote the manuscript; Chen N was involved in the acquisition of the data; Chen BY participated in manuscript writing; Yang HX revised the manuscript; Bi H performed the operation and revised the manuscript critically for important intellectual content; and All authors have read and approved the final manuscript.
Informed consent statement: Informed written consent was obtained from the patient for the publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hui Bi, MD, Chief Doctor, Department of Obstetrics and Gynaecology, Peking University First Hospital, Xishiku Street, Beijing 100034, China. bihuipku@163.com
Received: October 1, 2021
Peer-review started: October 1, 2021
First decision: January 11, 2022
Revised: January 20, 2022
Accepted: February 23, 2022
Article in press: February 23, 2022
Published online: April 6, 2022
Processing time: 179 Days and 8.2 Hours
Core Tip

Core Tip: Despite chronic lung disease and malignant tumors, uterine myoma can also be the cause of secondary erythrocytosis, the mechanisms of which may be ectopically produced erythropoietin originating from the leiomyoma. A multidisciplinary team is strongly recommended to ensure that the patient has received the optimal treatment and has a good prognosis.